Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Recruiting · NCT06132438 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-09-15 | NCT06132438 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Charlotte Lemech | 1 |
| The University of New South Wales | 23 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ingham Institute of Applied Medical Research | Liverpool | Australia | 1 |
| Scientia Clinical Research | Randwick | Australia | 20 |